Literature DB >> 15802733

Risks of gene therapy should be weighed against lack of alternatives for many diseases.

Robert E MacLaren, Robin R Ali, Adrian J Thrasher.   

Abstract

Keywords:  Genetics and Reproduction

Mesh：

Year:  2005        PMID： 15802733      PMCID： PMC555925          DOI： 10.1136/bmj.330.7494.791-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

Authors:  Matthew P McCormack; Terence H Rabbitts
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

Review 2.  Recent developments in gene transfer: risk and ethics.

Authors:  Jonathan Kimmelman
Journal:  BMJ       Date:  2005-01-08

3.  Assessment of risk of cancer after renal transplantation.

Authors:  C G Newstead
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.